Patient Needs, Perceptions, and Attitudinal Drivers Associated with Obesity: A Qualitative Online Bulletin Board Study.


Journal

Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864

Informations de publication

Date de publication:
04 2019
Historique:
received: 02 12 2018
pubmed: 13 3 2019
medline: 2 5 2020
entrez: 13 3 2019
Statut: ppublish

Résumé

To gain insights into the needs, attitudes, perceptions, and preferences of people living with obesity using an online bulletin board (OBB) study. The OBB is a moderated asynchronous online qualitative market research method that allows interactive discussion among participants. Participants were recruited via physician referral followed by screening questions to ensure eligibility and willingness to participate. The discussions in the OBB were moderated and allowed anonymized open answers and responses. Analysis was performed using various qualitative analytical tools. This OBB study included 23 participants (n = 11, UK; n = 12, USA). Participants expressed negative emotions associated with obesity. Obesity impacted various aspects of their life, and the feeling of loneliness caused food indulgence, especially during the evenings. Their appearance was their primary cause of anxiety, whilst health considerations were secondary. The participants felt trapped in a cycle where food was (ab)used to overcome problems associated with being obese. Participants were pessimistic about weight management measures as a result of unsuccessful past attempts, with little/no support from healthcare providers, friends, and family for weight management. They preferred medications that would allow them to maintain their current lifestyle yet cause visible weight reduction. Along with medications, they expressed a strong preference for an online support group with similar peers for motivation, support, and sustained outcomes. As losing excess weight is a challenge for most overweight individuals, the qualitative insights from this OBB can inform the planning and successful execution of various weight management and drug development programs. Novartis Pharma AG, Basel Switzerland.

Identifiants

pubmed: 30859499
doi: 10.1007/s12325-019-00900-1
pii: 10.1007/s12325-019-00900-1
pmc: PMC6824354
doi:

Banques de données

figshare
['10.6084/m9.figshare.7660616']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

842-857

Subventions

Organisme : Novartis Pharma AG, Basel Switzerland
ID : na
Pays : International

Références

Int J Clin Pract. 2016 Mar;70(3):196-205
pubmed: 26842304
Eur J Gen Pract. 2018 Dec;24(1):9-18
pubmed: 29199486
J Postgrad Med. 2017 Jul-Sep;63(3):182-190
pubmed: 28695871
Am J Mens Health. 2017 May;11(3):663-673
pubmed: 27702886
BMC Fam Pract. 2013 Dec 10;14:187
pubmed: 24321022
Diabetes Metab Syndr Obes. 2016 Feb 26;9:37-46
pubmed: 27013897
Adv Ther. 2019 Feb;36(2):478-491
pubmed: 30547371
Obes Rev. 2015 Apr;16(4):319-26
pubmed: 25752756
Behav Sci (Basel). 2017 Aug 14;7(3):
pubmed: 28805749
Eat Disord. 2011 Jul-Aug;19(4):295-307
pubmed: 22352970
Clin Obes. 2016 Jun;6(3):225-31
pubmed: 27097821
Eur Eat Disord Rev. 2016 Sep;24(5):377-82
pubmed: 27103100
Hum Reprod. 2016 Mar;31(3):498-501
pubmed: 26759142
JAMA. 2001 Nov 7;286(17):2160
pubmed: 11694161
BMC Public Health. 2009 Mar 25;9:88
pubmed: 19320986
JMIR Ment Health. 2015 Apr 24;2(2):e14
pubmed: 26543919
J Consult Clin Psychol. 1997 Feb;65(1):79-85
pubmed: 9103737
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):786-94
pubmed: 23703499
Child Obes. 2017 Dec;13(6):462-469
pubmed: 28727935
J Patient Rep Outcomes. 2018 Jun 19;2:28
pubmed: 29984351
Obesity (Silver Spring). 2014 Sep;22(9):1973-80
pubmed: 24942930
Obes Rev. 2017 Jul;18(7):715-723
pubmed: 28489290
Obes Rev. 2007 Jan;8(1):21-34
pubmed: 17212793
Eat Behav. 2007 Jan;8(1):132-5
pubmed: 17174861
Health Promot Perspect. 2013 Jun 30;3(1):11-22
pubmed: 24688948
Arch Gen Psychiatry. 2006 Jul;63(7):824-30
pubmed: 16818872
Nutr Rev. 2008 Dec;66(12):684-94
pubmed: 19019037
PLoS One. 2017 Jan 20;12(1):e0167571
pubmed: 28107449
Appetite. 2016 Jul 1;102:70-6
pubmed: 26898319

Auteurs

Nigel S Cook (NS)

Novartis Pharma AG, Basel, Switzerland. nigel.cook@novartis.com.

Pradhumna Tripathi (P)

Novartis Healthcare Pvt. Ltd., Hyderabad, India.

Olivia Weiss (O)

Ipsos Suisse SA, Basel, Switzerland.

Susann Walda (S)

Ipsos Suisse SA, Basel, Switzerland.

Aneesh T George (AT)

Novartis Healthcare Pvt. Ltd., Hyderabad, India.

Andrew Bushell (A)

Novartis Pharma AG, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH